Trials / Withdrawn
WithdrawnNCT05990478
A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer
Contrast-Enhanced Mammography With Early and Delayed Acquisitions in the Assessment of the Extent of Residual Disease Following Neoadjuvant Treatment in Patients With Breast Cancer
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out whether Contrast-Enhanced Mammography/CEM scans performed 2 minutes and 6 minutes after receiving Iohexol contrast dye can be used to identify the amount of residual disease in the breast following neoadjuvant treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Contrast-Enhanced Mammography | Participants will have pre- and post-treatment CEM of the affected breast |
| DIAGNOSTIC_TEST | Breast MRI | Pre- and post-NAT breast MRI will be performed for all participants |
Timeline
- Start date
- 2023-08-03
- Primary completion
- 2024-07-26
- Completion
- 2024-07-26
- First posted
- 2023-08-14
- Last updated
- 2025-05-21
Source: ClinicalTrials.gov record NCT05990478. Inclusion in this directory is not an endorsement.